MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma

被引:13
|
作者
Li, Hai Ming [1 ,2 ]
Qiang, Jin Wei [1 ]
Xia, Gan Lin [2 ]
Zhao, Shu Hui [3 ]
Ma, Feng Hua [1 ]
Cai, Song Qi [1 ]
Feng, Feng [2 ]
Fu, Ai Yan [2 ]
机构
[1] Fudan Univ, Jinshan Hosp, Shanghai Med Coll, Dept Radiol, Shanghai 201508, Peoples R China
[2] Nantong Univ, Nantong Canc Hosp, Dept Radiol, Nantong 226361, Jiangsu, Peoples R China
[3] Jiaotong Univ, Xinhua Hosp, Shanghai Med Coll, Dept Radiol, Shanghai 200092, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Ovary; Endometroid carcinoma; High-grade serous carcinoma; Magnetic resonance imaging; Diffusion-weighted imaging; FERTILITY-SPARING SURGERY; YOUNG-WOMEN; CANCER; NEOPLASMS; SUBTYPES;
D O I
10.1186/s13048-015-0154-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: To investigate magnetic resonance imaging (MRI) features for differentiating ovarian endometrioid adenocarcinoma (OEC) from high-grade serous adenocarcinoma (HGSC). Materials and methods: Twenty-three patients with 25 OECs and 93 patients with 139 HGSCs confirmed by surgery and pathology underwent conventional MRI and diffusion-weighted imaging (DWI). The MRI features of the tumors, including laterality, size, shape, configuration, signal intensity, ADC value of solid component, enhancement, ascites, synchronous primary cancer (SPC) of the ovary and endometrium, and clinical stage, were evaluated and compared between two groups. Results: The following characteristics were significantly more common for OECs than HGSCs: unilateral (91.3% vs 50.5%, P < 0.001), larger mass (80.0% vs 48.2%, P = 0.005), round or oval shape (64.0% vs 17.3%, P < 0.001), mainly cystic with mural nodules or papillary projections (72.0% vs 18.7%, P < 0.001), cystic component with homogeneous iso-or hyperintensity on T1WI (82.6% vs 4.3%, P < 0.001), moderate enhancement (52.0% vs 26.6%, P = 0.011), no or mild ascites (91.3% vs 57.0%, P = 0.002), and SPC (43.5% vs 4.3%, P < 0.001). The ADC value of the solid component was higher in OECs (0.979 +/- 0.197 x 10(-3) mm(2)/s) than in HGSCs (0.820 +/- 0.112 x 10(-3) mm(2)/s) (P = 0.002). When a mainly cystic mass with mural nodules or papillary projections was associated with any one of homogeneously iso-or hyperintense cystic component on TIWI, a relatively higher ADC value and SPC, the sensitivity, specificity, accuracy, and positive and negative predictive values for characterizing OEC were 87.0%, 93.5%, 92.2%, 76.9%, and 96.7%, respectively. Conclusions: Conventional MRI combining DWI is helpful for differentiating OECs from HGSCs.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Homologous recombination mutations and overall survival in high-grade serous, endometrioid, and clear cell ovarian carcinomas
    Harrell, Maria I.
    Maurer, Matthew J.
    Heinzen, Ethan P.
    Lee, Ming K.
    Kalli, Kimberly R.
    Agnew, Kathy J.
    Oberg, Ann L.
    Walsh, Tom
    Norquist, Barbara M.
    Hartmann, Lynn C.
    Kaufmann, Scott H.
    Swisher, Elizabeth M.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [32] Biomarkers of outcome with weekly paclitaxel in platinum-resistant high-grade serous or endometrioid ovarian carcinoma
    Madariaga, A.
    Garg, S.
    Bruce, J.
    Rath, P.
    Mandilaras, V.
    Thiryayi, S.
    Oza, A. M.
    Dhani, N.
    Lee, Y. C.
    Clarke, B. A.
    Lheureux, S.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 149 - 149
  • [33] Management of high-grade ovarian adenocarcinoma in an intraperitoneal pelvic renal transplant recipient
    Demirel, Esra
    Cohen, Seth
    Ennis, Ronald D.
    Nezhat, Farr R.
    GYNECOLOGIC ONCOLOGY REPORTS, 2024, 55
  • [34] PAX8 Expression Is Useful To Distinguish Dedifferentiated Endometrioid Adenocarcinoma from Grade III Endometrioid Adenocarcinoma
    Li, Z.
    Gao, F.
    Hong, W.
    Zhao, C.
    MODERN PATHOLOGY, 2013, 26 : 286A - 286A
  • [35] PAX8 Expression Is Useful To Distinguish Dedifferentiated Endometrioid Adenocarcinoma from Grade III Endometrioid Adenocarcinoma
    Li, Z.
    Gao, F.
    Hong, W.
    Zhao, C.
    LABORATORY INVESTIGATION, 2013, 93 : 286A - 286A
  • [36] The expression profile and prognostic value of APE/Ref-1 and NPM1 in high-grade serous ovarian adenocarcinoma
    Fan, Xiaomei
    Wen, Lixuan
    Li, Yuehong
    Lou, Lei
    Liu, Weina
    Zhang, Jun
    APMIS, 2017, 125 (10) : 857 - 862
  • [37] Expression of interferon stimulated gene 15 is a novel prognostic predictor for patients with advanced stage high-grade serous ovarian adenocarcinoma
    Tsai, Ching-Chou
    Zaid, Tarrik M.
    Co, Chloe N.
    Yeung, Tsz-Lun
    Thompson, Melissa S.
    Carroll, Amy
    Yeung, Zachary P.
    Wong, Kwong-Kwok
    Mok, Samuel C.
    CANCER RESEARCH, 2011, 71
  • [38] Ovarian involvement in endometrioid adenocarcinoma of uterus
    Lin, Ken Y.
    Miller, David S.
    Bailey, April A.
    Andrews, Sajan J.
    Kehoe, Siobhan M.
    Richardson, Debra L.
    Lea, Jayanthi S.
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 532 - 535
  • [39] Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
    Karst, Alison M.
    Levanon, Keren
    Drapkin, Ronny
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (18) : 7547 - 7552
  • [40] SALIVARY DUCT ADENOCARCINOMA - A HIGH-GRADE MALIGNANCY
    HUI, KK
    BATSAKIS, JG
    LUNA, MA
    MACKAY, B
    BYERS, RM
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1986, 100 (01): : 105 - 114